TetraLogic Pharmaceuticals Corporation (NasdaqGM:TLOG) has filed a Shelf Registration in the amount of $150 million. The net proceeds will be used for general corporate purposes, including working capital, continued development of product candidate pipeline, acquisitions, retirement of debt and other business opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -99.00% |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 24 | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- TLOG Stock
- News TetraLogic Pharmaceuticals Corporation
- TetraLogic Files Shelf Registration; Mulls Acquisitions